MedTrace Logo

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

NCT05486351 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 318

Last updated 2022-08-03

No results posted yet for this study

Summary

This is an observational, prospective, multicenter, cohort study in patients with cardioembolic stroke and previous oral or parenteral anticoagulant therapy. Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted, in terms of stroke or systemic embolism and haemorrhagic transformation.

Conditions

  • Cardioembolic Stroke
  • Anticoagulant Therapy
  • Stroke Recurrence
  • Haemorrhagic Transformation Stroke

Interventions

OTHER

Observation

Patients are observed for stroke or systemic embolism and haemorrhagic transformation

Sponsors & Collaborators

  • Hospital Universitario La Paz

    collaborator OTHER

  • Daiichi Sankyo

    collaborator INDUSTRY

  • Fundación Freno al ICTUS

    collaborator UNKNOWN

  • Instituto de Investigación Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Ricardo Rigual Bobillo, MD · Hospital Universitario La Paz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-05
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • France
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05486351 on ClinicalTrials.gov